Table 2.
Associations between muscle mass and NAFLD (n=320)
| Variables | NAFLD assessed by US | NAFLD assessed by MRI | NAFLD assessed by CNS |
|---|---|---|---|
| ASM/Wt (%) | |||
| Model 1 | 2.68 (1.59, 4.52) | 1.92 (1.11, 3.31) | 3.51 (2.04, 6.06) |
| Model 2 | 2.66 (1.56, 4.54) | 1.97 (1.13, 3.43) | 3.44 (2.00, 5.96) |
| Model 3 | 3.00 (1.70, 5.31) | 2.00 (1.13, 3.53) | 3.39 (1.73, 6.65) |
| ASM/BMI | |||
| Model 1 | 1.45 (0.91, 2.33) | 1.41 (0.88, 2.27) | 2.19 (1.31, 3.68) |
| Model 2 | 1.55 (0.92, 2.52) | 1.44 (0.89, 2.35) | 2.17 (1.29, 3.66) |
| Model 3 | 1.71 (1.02, 2.86) | 1.50 (0.90, 2.48) | 1.95 (1.04, 3.65) |
| ASM/ht² | |||
| Model 1 | 1.28 (0.68, 2.42) | 0.94 (0.50, 1.74) | 1.63 (0.76, 3.52) |
| Model 2 | 1.12 (0.56, 2.21) | 0.95 (0.50, 1.79) | 1.47 (0.67, 3.24) |
| Model 3 | 1.09 (0.53, 2.26) | 0.90 (0.46, 1.75) | 1.37 (0.54, 3.46) |
Values are presented as odds ratio (95% confidence interval).
Model 1: adjusted for age and sex; Model 2: model 1+education, regular exercise, smoking and drinking; Model 3: model 2+hypertension, diabetes mellitus, and dyslipidemia.
NAFLD, non-alcoholic fatty liver disease; US, ultrasonography; MRI, magnetic resonance imaging; CNS, comprehensive NAFLD score; ASM, appendicular skeletal muscle mass; Wt, weight; BMI, body mass index; ht, height.